AR-501
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AR-501, covering 2023-03-09 to 2023-03-09. Get the full timeline:
Most recent: Clinical Trial Update: SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects [Phase 1, Phase 2]